The Effect of Using Candesarsan and Amlodipine for Hypertensive Patients with Dyslipidemia in Japa
Not Applicable
Recruiting
- Conditions
- Hypertension, Dyslipidemia
- Registration Number
- JPRN-UMIN000005817
- Lead Sponsor
- The Cardiovascular Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1.Malignancy 2.Contraindication to take candesartan, amlodipine and pitabastatin. 3.Familial hypercholesterolemia 4.Acute coronary syndrome 5.Already enrollment other clinical trials. 6.Mismatched patients
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The blood pressure-lowering effect was not significant difference among candesartan and amlodipine groups. Moreover, candesartan group was not worsening insulin resistance and the effect of lipid metabolism in hypertensive patients with dyslipidemia.
- Secondary Outcome Measures
Name Time Method